Caren Deardorf - 01 Aug 2022 Form 4 Insider Report for Magenta Therapeutics, Inc. (DNTH)

Role
Chief Commercial Officer
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Caren Deardorf
Issuer symbol
DNTH
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
4
Filing time
01 Aug 2022, 21:10:29 UTC
Previous filing
21 Jun 2022
Next filing
02 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNTH Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 01 Aug 2022 Common Stock 75,000 $1.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is August 1, 2022.